DYN

Biotechnology DYN NVS RNA Uncategorized

Dyne upgraded at Oppenheimer on upcoming trial readout from Avidity

Dec 10, 2025

Biotechnology DYN Uncategorized

Dyne Therapeutics prices $350 stock offering

Dec 10, 2025

Biotechnology DYN Uncategorized

Dyne Therapeutics announces $300M proposed public offering

Dec 8, 2025